Search Results - benjamin+johnson

2 Results Sort By:

Inhibition of the Mycobacterium Tuberculosis Virulence Using Ethoxzolamide

Executive SummaryTo address the pitfalls of traditional antibiotic tuberculosis therapies, such as the emergence of multi-drug resistant bacterial strains, alternative treatment strategies are currently being pursued. Researchers at Michigan State University (MSU) have developed a promising anti-virulence treatment strategy for Mycobacterium tuberculosis...
Published: 12/28/2016   |   Inventor(s): Robert Abramovitch, Benjamin Johnson, Christopher Colvin
Keywords(s):   Category(s): Medical, Pharmaceutical

Chemical Compounds that Limit Mycobacterium Tuberculosis Growth in Vitro or in Vivo

Executive SummaryMycobacterium tuberculosis (M. tuberculosis) causes the disease tuberculosis (TB) in humans. Driven by the hypoxic environment of the granuloma, M. tuberculosis enters a persistent, non-replicating state that is recalcitrant to antibiotic therapy. Treatment requires a multidrug, 6-9 month therapeutic regimen which has fueled the emergence...
Published: 10/14/2016   |   Inventor(s): Robert Abramovitch, Christopher Colvin, Benjamin Johnson
Keywords(s):   Category(s): Pharmaceutical, Medical